B Thompson to Disease-Free Survival
This is a "connection" page, showing publications B Thompson has written about Disease-Free Survival.
Connection Strength
0.032
-
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019 02; 7(2):154-162.
Score: 0.032